Estratto
Le malattie, quale più quale meno, sono tutte per lo meno fastidiose, ma alcune sono dolorose o molto dolorose. Per secoli la malattia è stata interpretata come una punizione degli dei per una colpa commessa nei loro confronti1. Anche con il cristianesimo questa filosofia trova un accomodamento ed si instaura quindi meccanismo per cui colui che soffre cerca di trovare un peccato da espiare e, nel frattempo, cerca di trovare una scorciatoia nei confronti dell’Onnipotente. I santi sono allora le figure che meglio possono fare da tramite tra l’uomo e la divinità e, come nel Pantheon pagano, si cristallizzano delle facoltà soprannaturali per ogni evenienza. In mancanza di medicine efficaci la gente si rivolgeva (e molti ancora lo fanno!) al suo santo preferito o, meglio ancora, al santo “specializzato” per quella bisogna. Si identificano progressivamente i santi cui chiedere la guarigione di quella malattia particolare a tal punto che alcune malattie (es.: il fuoco di Sant’Antonio, il ballo di San Vito, ecc,) oppure alcuni rimedi classici della fitoterapia (l’erba di San Giovanni) vengono denominate col nome di santi.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Bibliografia
Generale
Alibert J-L. Clinique de l’hpital Saint-Louis ou traité complet des maladies de la peau. Cormon et Blanc, Paris, 1833
Atzei AD, Orrù L, Putzolu F, Rozzo G, Usala T. Le piante nelle terapie tradizionali. Sardegna sud-occidentale. Cagliari, STEF, 1994
Bateman T. Delineations of Cutaneous Diseases. Henry G. Bohn, London, 1840
Beswick TSL. The origin and the use of the word herpes. Medical History. 1982; VI:214–232
Black WJ. Folk Medicine. Burt Franklin, New York, 1970
Biesiada G, Krzemien J, Czepiel J, Teleglow A, Dabrowski Z, Spodaryk K, Mach T. Rheological properties of erythrocytes in patients suffering from erysipelas. Examination with LORCA device.Clin Hemorheol Microcirc. 2006; 34(3):383–390
Caetano M, Amorin I. [Erysipelas]. Acta Med Port. 2005; 18(5):385–393+
Cazenave A, Schedel HE. Abrégé pratique des maladies de la peau d’après les auteurs les plus estimés, et surtout d’après des documens puisés dans les leçons cliniques de Mr. le Dr. Biett. 2°édit. augm. Béchet, Paris, 1833
Chaumartin H. Le mal des ardents et le feu de Saint Antoine. Grenoble, 1947
Cox NH. Oedema as a risk factor for multiple episodes of cellulitis/erysipelas of the lower leg: a series with community follow-up. Br J Dermatol. 2006; 155(5):947–950
Del Giudice P, van der Mee-Marquet N, David-Rubin F, Le Duff F, Benchia K, Counillon E, Domelier AS, Quentin R. Severe relapsing erysipelas associated with chronic Streptococcus agalactiae vaginal colonization. Clin Infect Dis. 2006;43(7):e67–70
De Marliave O. Sources des landes de Gascogne. Bordeaux, Horizon chimérique. 1982, p. 77. Citato in: Cosson G. Guérir avec les saints. Paris, Cerf. 2000.
Edwards J, Green P, Haase D. A blistering disease: bullous erysipelas. CMAJ. 2006; 175(3):244
Goettsch WG, Bouwes Bavinck JN, Herings RM. Burden of illness of bacterial cellulitis and erysipelas of the leg in the Netherlands. J Eur Acad Dermatol Venereol. 2006; 20(7):834–839
Hofmann A. History of the discovery of LSD. In: Pletscher A, Ladewig D (Eds). Fifty years of LSD. Partheneon, New York, London, 1994
Imbault-Huart MJ. Le mal des ardents. In: LeGoff J., Sournia JC. (eds) Les maladies ont une historic L’histoire/Seuil, 1985
Martin JM, Green M. Group A streptococcus. Semin Pediatr Infect Dis. 2006; 17(3):140–148
Masmoudi A, Maaloul I, Turki H, Elloumi Y, Marrekchi S, Bouassida S, Ben Jemaa M, Zahaf A. Erysipelas after breast cancer treatment (26 cases). Dermatol Online J. 2005; 11(3):12
Mischlewski A. Un ordre hospitalier au Moyen Age. Les chanoines réguliers de Saint-Antoine-en-Viennois. Presses Universitaires de Grenoble, 1995
Morris A. Cellulitis and erysipelas. Clin Evid. 2006; (15):2207–2211
Pitré G. Medicina popolare siciliana. Il vespro, Palermo, 1978
Pletscher A, Ladewig D (Eds). Fifty years of LSD. Partheneon, New York, London, 1994
Poitou C. Ergotisme, ergot de seigle et épidemies en Sologne au XVIII siècle. Rev. Hist. Mod. Cont, 1976; 23: 354–368
Potter BS. Bibliographic landmarks in the history of dermatology. J Am Acad Dermatol. 2003; 48(6):919–932
Rayer PR Traité théorique et pratique des maladies de la peau. J. B. Baillière, Paris, 1835
Renzetti E, Tafani R. Sulla pelle del villano. San Michèle all’Adige. 1988
Schachner LA, Hansen RC. Pédiatric Dermatology. Churchill Livingston, New York, 1988
Vignes S, Dupuy A. Recurrence of lymphoedema-associated cellulitis (erysipelas) under prophylactic antibiotherapy: a retrospective cohort study. J Eur Acad Dermatol Venereol. 2006; 20(7):818–822
Herpes zoster
Alessi E, Cusini M, Zerboni R et al. Unusual varicella zoster virus infection in patients with the acquired immunodeficiency syndrome. Arch Dermatol 1988; 124:1011–1013
Arvin AM, Greenberg HB. New viral vaccines. Virology, 2006; 344(1):240–249
Bader MS, McKinsey DS. Viral infections in the elderly. The challenges of managing herpes zoster, influenza, and RSV. Postgrad Med. 2005; 118(5):45–48, 51–54
Bartlett JG. Recent developments in the management of herpes simplex virus infection in HIV-infected persons. Clin Infect Dis. 2004; 39:S237–S239
Chakrabarty A, Tyring SK, Beutner K, Rauser M. Recent clinical experience with famciclovir: a „third generation“ nucleoside prodrug. Antivir Chem Chemother. 2004; 15(5):251–253
Crawford D. Il nemico invisibile. Storia naturale dei virus. Raffaello Cortina Editore, Milano, 2002
De Clercq E. Discovery and development of BVDU (brivudin) as a therapeutic for the treatment of herpes zoster. Biochem Pharmacol. 2004; 68(12):2301–2315
Douglas MW, Johnson RW, Cunningham AL. Tolerability of treatments for postherpetic neuralgia. Drug Saf. 2004; 27(15):1217–1233
Feder HM Jr, Hoss DM. Herpes zoster in otherwise healthy children. Pediatr Infect Dis J. 2004; 23(5):451–457; quiz 458–460
Feller L, Jadwat Y. Herpes zoster: a review of the literature and report of a case. SADJ. 2005; 60(9):380–382, 384
Fritsch. Dermatologie und Venerologie. Lehrbuch und Atlas. Springer, Berlin Heidelberg New York, 1998
Gilden D. Varicella Zoster Virus and Central Nervous System Syndromes. Herpes 2004; 11(Suppl 2):88–94
Gilden DH, Cohrs RJ, Mahalingam R. VZV vasculopathy and postherpetic neuralgia: progress and perspective on antiviral therapy. Neurology. 2005; 64(1):21–25
Gnann JW Jr. Varicella-zoster virus: atypical presentations and unusual complications. J Infect Dis 2002; 186(Suppl 1):S91–S98
Hambleton S, Gershon AA. Preventing varicella-zoster disease. Clin Microbiol Rev. 2005; 18(1):70–80
Heath RB, Kangro HO. Varicella-Zoster. In: Zuckerman AJ et al (eds) Virologia clinica, 2°ed. Centra Scientifico Editore, pp 49–75, 1994
Hollier LM, Grissom H. Human herpes viruses in pregnancy: cytomegalovirus, Epstein-Barr virus, and varicella zoster virus. Clin Perinatol. 2005; 32(3):671–696
Insinga RP et al. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med 2005; 20:748–845
Johnson RW. Pain following herpes zoster: implications for management. Herpes 2004; 11(3): 63–65
Jumaan AO et al. Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992–2002. J Infect Dis 2005; 191:2002–2007
Katsambas A, Lotti T. European Handbook of Dermatological Treatments. Springer, Berlin Heidelberg New York, 2004
Koutsky LA et al. Underdiagnosis of genital herpes by current clinical and viral isolation procedures. N Engl J Med 1992; 326:1533–1539
Ku CC, Besser J, Abendroth A, Grose C, Arvin AM. Varicella-Zoster virus pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu mouse model. J Virol. 2005; 79(5):2651–2658
Kurlan JG, Connelly BL, Lucky AW. Herpes zoster in the first year of life following postnatal exposure to varicella-zoster virus: four case reports and a review of infantile herpes zoster. Arch Dermatol. 2004; 140(10):1268–1272
Lafferty WE et al. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N Engl J Med 1987; 316:14441–14449
Lautenschlager S, Eichmann A. The heterogeneous clinical spectrum of genital herpes. Dermatology 2001; 202:211–219
Levin MJ et al (2004) Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients. CID 2004; 39(Supp 5):S248–S257
Longson M. Herpes simplex. In: Zuckerman AJ et al (eds) Virologia clinica, 2°ed. Centra Scientifico Editore, pp 3–48, 1994
Malkin JE. Epidemiology of genital herpes simplex virus infection in developed countries. Herpes. 2004; (Suppl 1):2A–23A
Mertz GJet al. Is Herpes simplex virus type 1 (HSV-1) now more common than HSV-2 in first episode of genital herpes? Sex Transm Dis 2003; 30:801–802
Mori I, Nishiyama Y. Herpes simplex virus and varicella-zoster virus: why do these human alphaherpesviruses behave so differently from one another? Rev Med Virol. 2005; 15(6):393–406
Morrone A, Hercogova J, Lotti T (2004). Dermatology of human mobile population. MNN Publishing, 2005
Munday PE et al. Clinical uses of herpes simplex virus ype-specific serology. Int J STD & AIDS 2001; 12:784–788
Oxman MN, Levin MJ, Johnson GR et al. Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352:2271–2284
Patel R. Educational interventions and the prevention of herpes simplex virus transmission. Herpes. 2004; (Suppl 3):15A–159A
Pebody RG et al. The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex Transm Infect 2004; 80:185–191
Reyes M et al. Acyclovir-resistant genital herpes among persons attending sexually transmitted disease and human immunodeficiency virus clinics. Arch Intern Med 2003; 163:76–80
Ruocco V. et al. Tzanck smear, an old test for the new millennium: when and how. Int J Dermatol 1999; 38:830–834
Samaratunga H, Weedon D, Musgrave N, McCallum N. Atypical presentation of herpes simplex (chronic hypertrophic herpes) in a patient with HIV infection. Pathology 2001; 33:532–535
Sandy MC. Herpes zoster: medical and nursing management. Clin J Oncol Nurs. 2005;9(4):443–446
Sartori AM. A review of the varicella vaccine in immunocompromised individuals. Int J Infect Dis. 2004; 8(5):259–270
Schachner L, Hansen RC. Pediatric Dermatology. Elsevier, 2004
Siegal FP. et al. Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med 1981; 305:1439–1444
Sterling JC. Virus infections. In: Burns T, Breathnach S,. Cox N, Griffiths C. (eds) Rook’s textbook of dermatology, 7°ed. Blackwell Science, pp 15–22, 2004
Suligoi B, Torri A, Grilli et al-The Italian Herpes Management Forum. Seroprevalence and seroincidence of herpes simplex virus type 1 and herpes simplex virus type 2 infections in a cohort of adolescents in Italy. Sex Transm Dis 2004; 31:608–610
Volpi A, Gross G, Hercogova J, Johnson RW. Current management of herpes zoster: the European view. Am J Clin Dermatol. 2005; 6(5):317–325
Volpi A, Gross G, Hercogova J, Johnson RW. Current management of herpes zoster. The European view. Am J Clin Dermatol 2005;6:317–325
Wareham D. Postherpetic neuralgia. Clin Evid. 2004; (12):1182–1193
Whitley RJ, Meheus A. (eds). The public health significance of genital herpes. http://www.ihmf.org
Yih WK, Brooks DR, Lett SM et al. The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998–2003. BMC Public Health 2005; 5:68
Zareba G. Pregabalin: a new agent for the treatment of neuropathic pain. Drugs Today (Barc). 2005; 41(8):509–516
Erisipela
Biesiada G, Krzemien J, Czepiel J, Teleglow A, Dabrowski Z, Spodaryk K, Mach T. Rheological properties of erythrocytes in patients suffering from erysipelas. Examination with LORCA device. Clin Hemorheol Microcirc. 2006; 34(3):383–390
Caetano M, Amorin I. [Erysipelas]. Acta Med Port. 2005; 18(5):385–393
Cox NH. Oedema as a risk factor for multiple episodes of cellulitis/erysipelas of the lower leg: a series with community follow-up. Br J Dermatol. 2006; 155(5):947–950.
Del Giudice P, van der Mee-Marquet N, David-Rubin F, Le Duff F, Benchia K, Counillon E, Domelier AS, Quentin R. Severe relapsing erysipelas associated with chronic Streptococcusagalactiae vaginal colonization.Clin Infect Dis. 2006;43(7):e67–70.
Edwards J, Green P, Haase D. A blistering disease: bullous erysipelas. CMAJ. 2006; 175(3):244.
Goettsch WG, Bouwes Bavinck JN, Herings RM. Burden of illness of bacterial cellulitis and erysipelas of the leg in the Netherlands. J Eur Acad Dermatol Venereol. 2006; 20(7):834–839.
Martin JM, Green M. Group A streptococcus. Semin Pediatr Infect Dis. 2006; 17(3):140–148.
Masmoudi A, Maaloul I, Turki H, Elloumi Y, Marrekchi S, Bouassida S, Ben Jemaa M, Zahaf A. Erysipelas after breast cancer treatment (26 cases). Dermatol Online J. 2005; 11(3):12.
Morris A. Cellulitis and erysipelas. Clin Evid. 2006; (15):2207–2211
Vignes S, Dupuy A. Recurrence of lymphoedema-associated cellulitis (erysipelas) under prophylactic antibiotherapy: a retrospective cohort study. J Eur Acad Dermatol Venereol. 2006; 20(7):818–822
Ergotismo
Aaronson S. Fungal parasites of grasses and cereals: their role as food or medicine, now and in the past. Antiquity. 1989; 63: 247–257
Aeby A, Johansson AB, De Schuiteneer B, Blum D. Methylergometrine poisoning in children: review of 34 cases. J Toxicol Clin Toxicol. 2003; 41:249–253
Ainsworth S. Burn the witch. Pract Midwife. 2005; 8:46
Arnheim K. Digitalis poisoning, myopathy, ergotism. When antibiotic and associated therapy become dangerous mixture. MMW Fortschr Med. 2003; 145:12–13
Bangh SA, Hughes KA, Roberts DJ, Kovarik SM. Neonatal ergot poisoning: a persistent iatrogenic illness. Am J Perinatol. 2005; 22:239–243
Boucharlat J, Istre M, Maitre A. St. Anthony’s Abbey and ergot poisoning. Ann Med Psychol (Paris). 1977; 2:871–878
Camporesi P. Il pane selvaggio. Il Mulino, Bologna, 1983
Caracci P. L’iconografia del malato, mutilato ai piedi, vuol sempre rappresentare il lebbroso? Pagine di Storia della Medicina. 1972; 16: 81–95
Christopoulos S, Szilagyi A, Kahan SR. Saint-Anthony’s Fire. Lancet. 2001; 358:1694
Colella D. Pagine di Storia della Medicina. 1969; 13: 68–77
Delaigue R. Le feu Saint-Antoine et l’étonnante intoxication ergotée. Armine-Ediculture, 2002
Dettelbacher W. About the acting of the brotherhood of St. Anthony in Wurzburg. Wurzbg Medizinhist Mitt. 2003; 22:81–88
Dotz W. Saint Anthony’s fire. Am J Dermatopathol. 1980; 2:249–253
Faure M. Ergotism, smallpox and halo-nevus at the onset of the sixteenth century. Ann Dermatol Venereol. 2003; 130(12 Pt 1):1182–1186
Gabbai I et al. Ergot poisoning at Pont-Saint-Esprit. Brit Med J. 1951; 2: 650–651
Garcia Ruiz PJ, Ruiz Ezquerro JJ, Garcia Torres A, Fanjul S. Ancient descriptions of movement disorders: Cathedral el Burgo de Osma (Soria, Spain). J Neurol. 2006; 253:731–734. Epub 2006 Mar 6
Girard PF. Le Mal des ardents ou le feu Saint-Antoine. Cah Méd. 1977; 12:691–698
Girard PF. Le Mal des ardents ou le feu Saint-Antoine. Cah Méd. 1977; 14:835–840
Girard PF. Le Mal des ardents ou le feu Saint-Antoine. Cah Méd. 1977; 9:465–471
Giraud G. Le pain maudit de Pont-Saint-Esprit et ses mystères. J Méd Montpellier. 1973; 8:413–427
Grasso V. Rassegna delle specie di Claviceps e delle loro piante ospiti. Parte I Ann Sperim Agr Roma 9, Suppl pp LI–LXXXIX, Parte II, ibid., Suppl pp XCVII–CXII, 1955
Hofmann A. LSD. My problem child. JP Tarcher, Los Angeles, 1983
Honein K, Boujaoude J, Chemaly M et al. How can a migraine cause faecal incontinence? Gut. 2005; 54:1817–1824
Jaffè A. in: Jung C.G. (ed) L’uomo e i suoi simboli. Casini, Firenze, Roma, 1967
Matossian MK. Poisons of the Past. Yale University Press, New Haven, 1989
Morgan JC, Sethi KD. Pergolide-induced ergotism. Neurology. 2006; 67:104
Naz I, Sophie Z. Acute limb ischemia due to ergotism. J Coll Physicians Surg Pak 2006; 16:553–555
Packer S, Dotz W. Epidemic ergotism, Saint Anthony’s fire, and Jewish mysticism. Dermatopathology, Practical & Conceptual. 1998; 4:259–268
Peraica M, Radiç B, Luciç A, Paloviç M. Toxic effects of mycotoxins in humans. Bull World Hearth Organ. 1999; 77:759–766
Perez Burkhardt JL. [Acute ischemia secondary to ergotism]. An Med Interna. 2004;21(2):101–102
Perrella G. Brain, mind and life. Erbarium. http://www.brainmindlife.org/erbarium.htm
Ruano-Calderon LA, Zermeno-Pohls R. Ergotism. A case report and review of the literature. Rev Neurol. 2005; 40:412–416
Sallansonnet-Froment M, Guegan-Massardier E, Blohorn-Sense Aet al. [Chronic ergotism: spinal lesion and neuropathy. Rev Neurol (Paris). 2004; 160:843–845
Samorini G. Neurotossicologia delle graminacee e dei loro patogeni vegetali: un’introduzione. Annali del Museo Civico di Rovereto. 1992; 7:253–264
Wasson RG, Hofmann A, Ruck CAP. The road to Eleusis. Harcourt Brace Jov, New York, 1978
Acrodinia
Beck C, Krafchik B, Traubici J, Jacobson S. Mercury intoxication: it still exists. Pediatr Dermatol. 2004; 21:254–259
Chrysochoou C, Rutishauser C, Rauber-Luthy C et al. An 11-month-old boy with psychomotor regression and auto-aggressive behaviour. Eur J Pediatr. 2003; 162:559–561
Dally A. The rise and fall of pink disease. Soc Hist Med 1997; 10:291–304
Fayez I, Paiva M, Thompson M et al. Toxicokinetics of mercury elimination by succimer in twin toddlers. Paediatr Drugs. 2005; 7:397–400
Horowitz Y, Greenberg D, Ling G, Lifshitz M. Acrodynia: a case report of two siblings. A Dis Child 2002; 86:453
Kazantzis G. Mercury exposure and early effects: an overview. Med Lav. 2002; 93:139–147
Rights and permissions
Copyright information
© 2007 Springer-Verlag Italia
About this chapter
Cite this chapter
(2007). Medicina. In: Il fuoco di Sant’Antonio. Springer, Milano. https://doi.org/10.1007/978-88-470-0595-2_3
Download citation
DOI: https://doi.org/10.1007/978-88-470-0595-2_3
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0594-5
Online ISBN: 978-88-470-0595-2
eBook Packages: MedicineMedicine (R0)